Search Nerddpedia

Hyperbaric Oxygen Therapy

** Hyperbaric oxygen therapy (HBOT) is a medical treatment that delivers 100 % oxygen at pressures greater than atmospheric pressure to accelerate healing and treat specific life‑threatening conditions. **CONTENT:** ## Overview Hyperbaric oxygen therapy (HBOT) involves placing a patient inside a sealed chamber where the ambient pressure is increased—typically to 1.5–3.0 atmospheres absolute (ATA)—while the patient breathes pure oxygen or an oxygen‑rich gas mixture. This elevation in pressure raises the **partial pressure of oxygen (pO₂)** in the lungs, blood plasma, and tissues far beyond what is achievable at normal sea‑level breathing. The result is a rapid influx of dissolved oxygen that can diffuse directly into cells, supporting metabolic processes even when red blood cells are compromised. The immediate physiological effects of HBOT include **reduction of gas bubble size** (by Boyle’s law) and **enhanced oxygen delivery** to ischemic or damaged tissues. These mechanisms make HBOT valuable for conditions where oxygen deficiency or gas emboli are central problems, such as decompression sickness, carbon‑monoxide poisoning, and certain infections like gas gangrene. Modern practice also extends to chronic wounds (e.g., diabetic foot ulcers), radiation‑induced tissue injury, and some neurologic injuries, though the evidence base varies. Because HBOT alters pressure and gas composition, it carries specific risks. **Barotrauma** to the ears, sinuses, or lungs can occur if pressure changes are not equalized properly. When pure oxygen is used, the chamber environment becomes highly flammable, necessitating strict fire‑safety protocols. Patients with certain lung diseases, uncontrolled pneumothorax, or certain medications (e.g., some chemotherapeutics) may be contraindicated. Anyone considering HBOT should first consult a qualified hyperbaric physician to weigh benefits against potential harms. ## History/Background The therapeutic use of increased ambient pressure dates back to the early 20th century, when divers and aviators observed that pressurizing the breathing environment alleviated symptoms of **decompression sickness (the “bends”)**. In 1911, French physician **Pierre Bouchard** reported successful treatment of divers using a pressurized chamber, laying groundwork for modern hyperbaric medicine. The first dedicated hyperbaric facility, the **U.S. Navy’s “Decompression Chamber”**, opened in 1915 at the Naval Hospital in Washington, D.C., primarily for submarine crews. During World II, the U.S. and Allied forces expanded hyperbaric use to treat **carbon‑monoxide poisoning** and **gas gangrene**, recognizing that high‑pressure oxygen could inhibit anaerobic bacteria and displace toxic CO from hemoglobin. The 1960s saw the establishment of civilian hyperbaric centers, and in 1967 the **U.S. Food and Drug Administration (FDA)** approved HBOT for specific indications, including decompression sickness and carbon‑monoxide poisoning. Subsequent decades added **chronic wound healing** (1990), **radiation tissue injury** (1997), and **ischemic stroke** (investigational) to the list of explored applications. International societies such as the **Undersea and Hyperbaric Medical Society (UHMS)** now publish evidence‑based guidelines that shape clinical practice worldwide. ## Key Information - **Mechanisms of Action:** ↑ pO₂ → ↑ dissolved oxygen in plasma; **vasoconstriction** reduces edema while maintaining oxygen delivery; **angiogenesis** and **fibroblast proliferation** promote tissue repair; **bactericidal effect** on anaerobes via oxidative stress. - **Typical Treatment Protocols:** Sessions last 60–120 minutes at 2.0–2.5 ATA; most conditions require 20–40 cumulative treatments, though acute emergencies (e.g., carbon‑monoxide poisoning) may need only 1–3 sessions. - **Approved Indications (FDA/UHMS):** Decompression sickness, arterial gas embolism, carbon‑monoxide poisoning, clostridial myonecrosis (gas gangrene), chronic refractory osteomyelitis, soft‑tissue radionecrosis, compromised skin grafts/flaps, and selected chronic wounds (diabetic foot ulcers, pressure injuries). - **Contraindications & Precautions:** Untreated pneumothorax, recent ear or sinus surgery, severe COPD with air trapping, uncontrolled seizures, and certain chemotherapy agents. Patients must undergo a pre‑treatment evaluation, including pulmonary function testing and tympanic membrane assessment. - **Adverse Effects:** Barotrauma (ear, sinus, pulmonary), oxygen toxicity seizures (rare, at >2.5 ATA for prolonged periods), hypoglycemia in diabetics, claustrophobia, and fire risk when using pure oxygen. - **Safety Measures:** Chambers are constructed of non‑combustible materials; all flammable items are removed; staff are trained in emergency decompression and fire suppression; patients are instructed on pressure‑equalization techniques. ## Significance HBOT represents a unique intersection of physics and medicine, turning the simple principle that “pressure increases gas solubility” into a life‑saving therapy. Its ability to **rapidly reverse hypoxia** makes it indispensable in acute toxic exposures (CO poisoning) and diving accidents, where minutes can determine neurological outcome. In chronic disease, HBOT offers a **non‑invasive adjunct** that can accelerate wound closure, reduce amputation rates in diabetic patients, and mitigate long‑term radiation damage, thereby improving quality of life and lowering healthcare costs. Beyond clinical outcomes, HBOT has spurred research into **oxygen‑mediated signaling pathways**, influencing fields such as regenerative medicine and neuroprotection. The therapy also underscores the importance of **multidisciplinary care**—hyperbaric physicians, nurses, respiratory therapists, and wound specialists must collaborate to ensure safe, evidence‑based use. Patients considering HBOT should always seek evaluation from a board‑certified hyperbaric specialist to confirm that the therapy is appropriate for their specific condition. **NOTE:** If you suspect you have a condition that might benefit from hyperbaric oxygen therapy—especially emergencies like carbon‑monoxide poisoning or decompression illness—seek immediate medical attention. Do not self‑refer to a chamber without professional guidance. **INFOBOX:** - Name: Hyperbaric Oxygen Therapy (HBOT) - Type: Medical treatment / Hyperbaric medicine - Date: First clinical use 1911 (modern protocols 1960s‑present) - Location: Worldwide; specialized hyperbaric chambers in hospitals, clinics, and naval facilities - Known For: Delivering 100 % oxygen at >1 ATA to treat decompression sickness, carbon‑monoxide poisoning, chronic wounds, and select infections **TAGS:** hyperbaric medicine, oxygen therapy, decompression sickness, carbon monoxide poisoning, wound healing, gas embolism, medical physics, patient safety